ME Therapeutics Provides Scientific Update on In Vivo CAR and Therapeutic mRNA Programs Life Science Investing
U.S. FDA Grants Priority Review of New Drug Application for Gilead's Once-Daily HIV Treatment of Bictegravir Plus Lenacapavir Life Science Investing
RenovoRx to Host First Quarter 2026 Financial Results and Business Highlights Conference Call on May 14th at 4:30 pm ET Life Science Investing
Candel Therapeutics Announces Commercialization Agreement with EVERSANA to Support Potential U.S. Launch of Aglatimagene Besadenovec in Localized Prostate Cancer Life Science Investing
Tempest to Advance Dual-Targeting CAR-T Platform with Clinical Update at ISCT 2026 Annual Meeting Life Science Investing
The Radoff-JEC Group Responds to Seer, Inc.'s Rejection of April 24th Acquisition Proposal Life Science Investing
Taysha Gene Therapies to Release First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 6 Life Science Investing
Cizzle Brands Corporation Announces Major Canadian Retail Expansion with Launch of CWENCH Hydration at Walmart Canada and Expanded Distribution Across Loblaws and Real Canadian Superstores Biotech Investing
